Altace and Joint contracture - a phase IV clinical study of FDA data

Summary:

Joint contracture is reported as a side effect among people who take Altace (ramipril), especially for people who are male, 50-59 old, also take Magnevist, and have Nuclear magnetic resonance imaging abdominal.

The phase IV clinical study analyzes which people have Joint contracture when taking Altace. It is created by eHealthMe based on reports of 23,086 people who have side effects when taking Altace from the FDA, and is updated regularly.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

What is Joint contracture?

Joint contracture (a permanent shortening of a muscle or joint) is found to be associated with 333 drugs and 653 conditions by eHealthMe. Check the latest studies of Joint contracture.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

23,086 people reported to have side effects when taking Altace.
Among them, 12 people (0.05%) have Joint contracture.

Among these 12 people:

What is the gender of people who have Joint contracture when taking Altace? *

female: 50 %
male: 50 %

What is the age of people who have Joint contracture when taking Altace? *

What are other drugs people take besides Altace? *

What are other side effects people have besides Joint contracture? *

Pain: 10 people, 83.33%
Mobility Decreased (ability to move is reduced): 10 people, 83.33%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 10 people, 83.33%
Scar: 8 people, 66.67%
General Physical Health Deterioration (weak health status): 8 people, 66.67%
Joint Range Of Motion Decreased (disease of joint movement): 8 people, 66.67%
Skin Induration (an abnormally hard spot or area on the skin): 8 people, 66.67%
Skin Hypertrophy (skin cells enlarges): 7 people, 58.33%
Weakness: 6 people, 50.00%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 6 people, 50.00%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 3 people, 25.00%
Nuclear Magnetic Resonance Imaging Abdominal: 3 people, 25.00%
Urinary Tract Infection: 1 person, 8.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 8.33%
Agitation (state of anxiety or nervous excitement): 1 person, 8.33%
Anaemia (lack of blood): 1 person, 8.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 8.33%
Back Pain: 1 person, 8.33%
Blood Count Abnormal: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Altace and have Joint contracture?

- Check whether Joint contracture is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Altace:

Altace (23,681 reports)

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint contracture:

Joint contracture (333 drugs)

Browse all the conditions that are associated with Joint contracture:

Joint contracture (653 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Altace) and Altace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.